Literature DB >> 15524406

Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice.

Xiao Su1, Mark Looney, Laurent Robriquet, Xiaohui Fang, Michael A Matthay.   

Abstract

Although several methods have been used to deliver fluid into the distal airspaces of the lung, the efficiency of these methods has been variable. Therefore, the authors have modified prior techniques to design a better method for direct visual instillation (DVI) of fluid into the trachea and compared its efficiency with two commonly used methods: nasal inhalation and invasive intratracheal instillation (delivery of the instillate by needle puncture of the trachea). The results showed that this method (DVI) can deliver fluid efficiently into either both lungs or into a single lung. Using an 131I-albumin labeling technique, DVI resulted in 92 +/- 1% retention of the labeled albumin in the lungs 1 hour after instillation, significantly greater than nasal inhalation (48 +/- 3%, P < .01) and invasive intratracheal instillation (77 +/- 3%, P < .05). Also, when bacteria (Escherichia coli) were instilled with the DVI method, the severity of gram-negative pneumonia was greater (6.5 +/- 0.5 g water/g dry weight) compared to delivery by nasal inhalation (5.5 +/- 0.4 g water/g dry weight, P < .05) or by invasive intratracheal instillation (5.9 +/- 0.4g water/g dry weight, P < .05). The authors conclude that DVI is more efficient than nasal inhalation and invasive intratracheal instillation for delivering experimental fluids into the distal airspaces of anesthetized mice. This method should be valuable for experimental lung studies in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15524406     DOI: 10.1080/01902140490476382

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  34 in total

1.  Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury.

Authors:  Walker M McHugh; William W Russell; Andrew J Fleszar; Paul E Rodenhouse; Skyler P Rietberg; Lei Sun; Thomas P Shanley; Timothy T Cornell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

2.  Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.

Authors:  Antoine Monsel; Ying-gang Zhu; Stephane Gennai; Qi Hao; Shuling Hu; Jean-Jacques Rouby; Michelle Rosenzwajg; Michael A Matthay; Jae W Lee
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

3.  SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity.

Authors:  Naveen Gupta; Roland Liu; Stephanie Shin; Ranjeet Sinha; Joseph Pogliano; Kit Pogliano; John H Griffin; Victor Nizet; Ross Corriden
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

4.  Deficiency of α7 nicotinic acetylcholine receptor attenuates bleomycin-induced lung fibrosis in mice.

Authors:  Peiyu Sun; Ling Li; Caiqi Zhao; Mengyao Pan; Zhikang Qian; Xiao Su
Journal:  Mol Med       Date:  2017-03-06       Impact factor: 6.354

5.  Mitogen-activated protein kinase phosphatase 2, MKP-2, regulates early inflammation in acute lung injury.

Authors:  Timothy T Cornell; Andrew Fleszar; Walker McHugh; Neal B Blatt; Ann Marie Le Vine; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-08       Impact factor: 5.464

6.  CD47 deficiency protects mice from lipopolysaccharide-induced acute lung injury and Escherichia coli pneumonia.

Authors:  Xiao Su; Mette Johansen; Mark R Looney; Eric J Brown; Michael A Matthay
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Authors:  Kathleen A Stringer; Meghan Tobias; John S Dunn; Jackie Campos; Zachary Van Rheen; Mitra Mosharraf; Rajiv Nayar
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

8.  Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury.

Authors:  Xiao Su; Michael A Matthay; Asrar B Malik
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury.

Authors:  Natalie J Serkova; Zachary Van Rheen; Meghan Tobias; Joshua E Pitzer; J Erby Wilkinson; Kathleen A Stringer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-25       Impact factor: 5.464

10.  Role of protease activated receptor 2 in experimental acute lung injury and lung fibrosis.

Authors:  Xiao Su; Michael A Matthay
Journal:  Anat Rec (Hoboken)       Date:  2009-04       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.